Integra LifeSciences Holdings (IART) — Capital Reinvestment Ratio
Latest as of March 2026:
1.51x
Integra LifeSciences Holdings (IART) has a Capital Reinvestment Ratio of 1.51x as of March 2026, meaning it reinvests 2% of its operating cash flow ($9.80 Million) in capital expenditures ($14.85 Million). See IART FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.51x
Capex / Operating Cash Flow
Operating Cash Flow
$9.80 Million
USD
Capital Expenditures
$14.85 Million
USD
Data as of
Mar 2026
Most recent filing
Integra LifeSciences Holdings Capital Reinvestment Ratio (1999–2025)
This chart tracks Integra LifeSciences Holdings's Capital Reinvestment Ratio across 26 annual periods.
Annual Capital Reinvestment Ratio for Integra LifeSciences Holdings (1999–2025)
Year-by-year Capital Reinvestment Ratio for Integra LifeSciences Holdings from 1999 to 2025. For live market cap and broader valuation context, see how much is Integra LifeSciences Holdings worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.62x | $50.38 Million | $81.44 Million | ▲ +100.3% |
| 2024 | 0.81x | $129.38 Million | $104.42 Million | ▲ +68.9% |
| 2023 | 0.48x | $139.96 Million | $66.86 Million | ▲ +168.4% |
| 2022 | 0.18x | $264.47 Million | $47.09 Million | ▲ +15.7% |
| 2021 | 0.15x | $312.43 Million | $48.08 Million | ▼ -50.9% |
| 2020 | 0.31x | $203.83 Million | $63.89 Million | ▼ -46.1% |
| 2019 | 0.58x | $231.43 Million | $134.53 Million | ▲ +49.3% |
| 2018 | 0.39x | $199.68 Million | $77.74 Million | ▲ +2.5% |
| 2017 | 0.38x | $114.54 Million | $43.50 Million | ▼ -6.6% |
| 2016 | 0.41x | $116.41 Million | $47.33 Million | ▲ +15.0% |
| 2015 | 0.35x | $94.48 Million | $33.41 Million | ▼ -33.7% |
| 2014 | 0.53x | $79.46 Million | $42.40 Million | ▼ -40.6% |
| 2013 | 0.90x | $53.27 Million | $47.85 Million | ▼ -23.6% |
| 2012 | 1.18x | $58.72 Million | $69.03 Million | ▲ +219.2% |
| 2011 | 0.37x | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $2.50 Million | $17.30 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow